S'abonner

Predictors of disease severity and outcomes in pediatric patients with croup and COVID-19 in the pediatric emergency department - 22/09/23

Doi : 10.1016/j.ajem.2023.06.050 
En-Pei Lee, M.D. a, b, Chun-Ting Mu, M.D. b, c, Chen-Wei Yen, M.D. b, d, e, Shao-Hsuan Hsia, M.D. a, b, Jainn-Jim Lin, M.D. a, b, Oi-Wa Chan, M.D. a, b, Chun-Che Chiu, M.D. b, f, Shen-Hao Lai, M.D. b, g, Wen-Chieh Yang h, i, Chun-Yu Chen h, i, Ya-Ting Su, M.D. b, j, Han-Ping Wu a, b, k,
a Division of Pediatric Critical Care Medicine, Department of Pediatrics, Chang Gung Memorial Hospital at Linko, Kweishan, Taoyuan, Taiwan 
b College of Medicine, Chang Gung University, Taoyuan, Taiwan 
c Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan 
d Division of Nephrology, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan 
e Division of Pediatric General Medicine, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan 
f Department of Pediatrics, Tucheng Composite Municipal Hospital, New Taipei City, Taiwan 
g Division of Pediatric Pulmonology, Department of Pediatrics, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan 
h Department of Pediatric Emergency, China Medical University Children's Hospital, China Medical University, Taichung City, Taiwan 
i Department of Medicine, College of Medicine, China Medical University, Taichung City, Taiwan 
j Division of Pediatric Endocrinology and Genetics, Department of Pediatrics, Chang Gung Memorial Hospital, Taipei, Taiwan 
k Department of Pediatrics, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan 

Corresponding author at: Department of Pediatrics, Chang Gung Memorial Hospital at Chiayi, No. 6, Sec. W., Jiapu Rd., Puzi City in Chiayi County, Taiwan.Department of PediatricsChang Gung Memorial Hospital at ChiayiNo. 6, Sec. W., Jiapu Rd., Puzi City in Chiayi CountyTaiwan

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Background

Croup caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging disease, and data on the risk factors associated with disease severity are still limited.

The Westley croup score (WS) is widely used to assess croup severity. The current study aimed to analyze biomarkers associated with the WS and clinical outcomes in patients with croup and coronavirus disease 2019 in the pediatric emergency department (PED).

Population and method

Patients diagnosed with croup caused by SARS-CoV-2 were admitted at two PEDs. Clinical data including age, WS, length of hospital stay, initial laboratory data, and treatment were analyzed. Clinical parameters were evaluated via multivariate logistic regression analysis. The best cutoff values for predicting croup severity and outcomes were identified using the receiver operating characteristic curve.

Result

In total, 250 patients were assessed. Moreover, 128 (51.2%) patients were discharged from the PED, and 122 (48.8%) were admitted to the hospital. Mild, moderate, and severe croup accounted for 63.6% (n = 159), 32% (n = 80), and 4.4% (n = 11) of all cases, respectively. A high mean age (years), neutrophil count (%), neutrophil-to-lymphocyte ratio (NLR), ALT (U/L), procalcitonin (ng/mL), and hemoglobin (g/dL) level, and length of hospital stay (days), and a low lymphocyte count (%) and blood pH were associated with croup severity and need for intensive care. Based on the multivariate logistic regression model, the NLR remained independent factors associated with croup severity and prognosis. Further, NLR was significantly correlated with WS. The area under the receiver operating characteristic curve of NLR for predicting a WS of ≥3 was 0.895 (0.842–0.948, p < 0.001), and that for predicting ICU admission was 0.795 (0.711–0.879, p < 0.001). The best cutoff values for a WS of ≥3 and ICU admission were 1.65 and 2.06, respectively.

Conclusion

NLR is correlated with WS and is a reliable, easy-to-use, and cheap biomarker for the early screening and prognosis of croup severity in the PED. A higher NLR may indicate severe croup and the need for further treatment. And the WS score remains reliable for estimating the severity of croup caused by SARS-CoV-2 and the risk of intensive care.

Le texte complet de cet article est disponible en PDF.

Keywords : COVID-19, Croup, Prognostic indicator, Pediatrics, Westley score


Plan


© 2023  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 72

P. 20-26 - octobre 2023 Retour au numéro
Article précédent Article précédent
  • The association of standard base excess upon emergency admission with outcomes in patients with heat stroke
  • Lan Chen, Xiaoling Yang, Junlu Zhao, Shuying Xu, Yuping Zhang, Xiuqin Feng
| Article suivant Article suivant
  • Association between post-cardiac arrest treatments and clinical outcomes according to scene time interval in out-of-hospital cardiac arrest: Retrospective cross-sectional study
  • Eujene Jung, Hyun Ho Ryu, Young Sun Ro, Sang Do Shin

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.